Iatrogenic Creutzfeldt-Jakob Disease

Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders: Second Edition

Volumn , Issue , 2011, Pages 381-386

  Ironside, James W ^a   Knight, Richard S G ^a   Head, Mark W ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Biochemistry; Blood; CJD; Creutzfeldt Jakob disease; Dura mater graft; Epidemiology; Human growth hormone; Iatrogenic CJD; Pathology; Prion protein gene; Transmission

Indexed keywords

EID: 84860336138     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444341256.ch39     Document Type: Chapter

References (28)

1. Duffy P, Wolf J, Collins G, DeVoe AG, Steen B, Cowen D. Possible person-to-person transmission of Creutzfeldt-Jakob disease. N Engl J Med 1974; 290:692-693.
2. Llewelyn CA, Hewitt PA, Knight RSG et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004; 363:417-4421.
3. Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 2004; 364:527-529.
4. Wroe SJ, Pal S, Siddique D et al. Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion:a case report. Lancet 2006; 368:2061-2067.
5. Health Protection Agency. Fourth case of transfusion-associated variant-CJD. Health Protection Report 2007; 1 (3). www.hpa.org.uk/hpr/archives/2007/hpr0307.pdf.
6. Peden AH, McCardle L, Head MW et al. Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia. Haemophilia 2010; 16(2):296-304.
7. Cochius JI, Burns RJ, Blumbergs PC, Mack K, Aldeman CP. Creutzfeldt-Jakob disease in a recipient of human pituitary-derived gonadotrophin. Aust NZ J Med 1990; 20:592-593.
8. Cochius JI, Hyman N, Esiri MM. Creutzfeldt-Jakob disease in a recipient of human pituitary-derived gonadotrophion:a second case. J Neurol Neurosurg Psychiatry 1992; 55:1094-1095.
9. Heckmann JG, Lang CJG, Petruch F et al. Transmission of Creutzfeldt-Jakob disease via a corneal transplant. J Neurol Neurosurg Psychiatry 1997; 63:388-390.
10. Uchiyama K, Ishida C, Yago S, Kuramaya H, Kitamoto T. An autopsy case of Creutzfeldt-Jakob disease associated with corneal transplantation. Dementia 1994; 8:466-473.
11. Will RG. Acquired prion disease:iatrogenic CJD, variant CJD, kuru. Br Med Bull 2003; 66:255-265.
12. Brown P, Brandel JP, Preece M, Sato T. Iatrogenic Creutzfeldt-Jakob disease:the waning of an era. Neurology 2006; 67:389-393.
13. Brandel JP, Preece M, Brown P et al. Distribution of codon 129 genotype in human growth hormone-treated CJD patients in France and the UK. Lancet 2003; 362:128-130.
14. Heath CA, Barker RA, Esmonde TFG et al. Dura mater-associated Creutzfeldt-Jakob disease:experience from surveillance in the UK. J Neurol Neurosurg Psychiatry 2006; 77:880-882.
15. Brown P, Preece M, Brandel JP et al. Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology 2000; 55:1075-1081.
16. Swerdlow AJ, Higgins CD, Adlard P, Jones ME, Preece MA. Creutzfeldt-Jakob disease in United Kingdom patients treated with human pituitary growth hormone. Neurology 2003; 61:783-791.
17. Houston F, McCutcheon S, Goldmann W et al. Prion diseases are efficiently transmitted by blood transfusion in sheep. Blood 2008; 112:4739-4745.
18. Huillard d'Aignaux J, Costagliola D, Maccano J et al. Incubation period of Creutzfeldt-Jakob disease in human growth hormone recipients in France. Neurology 1999; 53:1197-1201.
19. Brandel JP, Peoc'h K, Beaudry P et al. 14-3-3 protein cerebrospinal fluid detection in human growth hormone-treated Creutzfeldt-Jakob disease patients. Ann Neurol 2001; 49:257-260.
20. Ironside JW, Ghetti B, Head MW, Piccardo P, Will RG. Prion diseases. In:Love S, Louis DN, Ellison DW (eds) Greenfield's Neuropathology, 8th edn. London:Hodder Arnold, 2008, pp. 1197-1273.
21. Ironside J, Bishop M, McCardle L, Ritchie D, Head M. PRNP codon 129 genotype and PrPres isoform are major phenotypic determinants in hGH iatrogenic CJD cases in the UK. Prion 2009 conference abstract, P03.131, 79.
22. Satoh K, Muramoto T, Tanaka T et al. Association of an 11-12 kDa protease-resistant prion protein fragment with subtypes of dura mater-associated Creutzfeldt-Jakob disease and other prion diseases. J Gen Virol 22003; 83:2885-2893.
23. Goodbrand IA, Ironside JW, Nicholson D, Bell JE. Prion protein accumulation in the spinal cords of patient with sporadic and growth-hormone associated Creutzfeldt-Jakob disease. Neurosci Lett 1995; 183:127-130.
24. Peden AH, Ritchie DL, Head MW, Ironside JW. Detection and localization of PrPSc in the skeletal muscle of patients with variant, iatrogenic, and sporadic forms of Creutzfeldt-Jakob disease. Am J Pathol 2006; 168:927-935.
25. Liberski PP, Streichenberger N, Giraud P et al. Ultrastructural pathology of prion diseases revisited:brain biopsy studies. Neuropathol Appl Neurobiol 2005; 31:88-96.
26. Head MW, Yull HM, Ritchie DL, Bishop MT, Ironside JW. Pathological investigation of the first blood donor and recipient pair linked by transfusion-associated variant Creutzfeldt-Jakob disease transmission. Neuropathol Applied Neurobiol 2009; 35:433-436.
27. Holmes SJ, Ironside JW, Shalet SM. Neurosurgery in a patient with Creutzfeldt-Jakob disease after pituitary derived growth hormone therapy in childhood. J Neurol Neurosurg Psychiatry 1996; 60:333-335.
28. Simpson DA, Masters CL, Ohlrich G, Purdie G, Stuart G, Tannenberg AEG. Iatrogenic Creutzfeldt-Jakob disease and its neurosurgical implications. J Clin Neurosci 1996; 3:118-123.